Epicast report alzheimer’s disease epidemiology forecast to 2023

EpiCast Report: Alzheimer’s Disease Epidemiology Forecast to 2023

Single User License - $3995 Site User License - $7990 Corporate User License - $11985 Publication Date - Mar 2015 Pages - 82 To know more details, email to debora@reportstack.com

Contact: debora@reportstack.com Reportstack Market Research

Summary ď ś AD is an irreversible, neurodegenerative brain disease of the elderly, which leads to a progressive decline in memory and cognitive abilities, such as thinking, language, and learning capacity. Similar to AD, mild cognitive impairment (MCI) is also a condition of the elderly in which there is a slight but noticeable and measurable decline in cognitive abilities, including memory and thinking skills, but no dementia. ď ś To forecast the total prevalent cases of AD in adults ages =60 years in the 9MM during the forecast period (2013-2023), The epidemiologists identified country-specific population-based studies that used the diagnostic criteria based on the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, etc.

Contact: debora@reportstack.com Reportstack Market Research

Scope • The Alzheimer’s disease (AD) EpiCast Report provides an overview of the risk factors and global trends of AD in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and India).

The series also includes a 10-year epidemiological forecast for the total prevalent cases of AD segmented by sex, age, and severity in these markets. In addition, the report includes a 10year epidemiological forecast for the total prevalent cases of mild cognitive impairment (MCI) segmented by sex and age in these markets.

• The AD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

Contact: debora@reportstack.com Reportstack Market Research

Key Benefits - Develop business strategies by understanding the trends shaping and driving the global AD market.

- Quantify patient populations in the global AD market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AD therapeutics in each of the markets covered.

- Identify the percentage of AD prevalent cases by severity and identify the number of cases with MCI.

Contact: debora@reportstack.com Reportstack Market Research

If you are interested...

Contact : Debora White Email: debora@reportstack.com Ph:+1-888-789-6604 http://www.reportstack.com

Contact: debora@reportstack.com Reportstack Market Research